{"transactions":[{"id":733318,"issuer":{"id":6051,"kind":"organization","name":"Alector, Inc.","symbol":"ALEC"},"owners":[{"id":37117,"kind":"person","name":"GAROFALO ELIZABETH A.","position":1,"cik":"0001826361","reported_name":"GAROFALO ELIZABETH A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-17T20:05:16.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":9450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option vest in 12 equal monthly installments beginning on July 17, 2026, provided that the shares subject to the option will vest in full on the earlier of the one-year anniversary of the date of grant or the date of the Issuer's next annual meeting of stockholders."}],"balance_after":9450,"derivative":{"exercise_price":0,"expiration_date":"2036-06-16","underlying":"Common Stock","underlying_shares":9450},"source":{"system":"sec-edgar","filing":"0001193125-26-274132","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1653087/000119312526274132/ownership.xml","form_type":"4"}},{"id":733317,"issuer":{"id":6051,"kind":"organization","name":"Alector, Inc.","symbol":"ALEC"},"owners":[{"id":37117,"kind":"person","name":"GAROFALO ELIZABETH A.","position":1,"cik":"0001826361","reported_name":"GAROFALO ELIZABETH A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-17T20:05:16.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":28700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares are represented by restricted stock units, or RSUs, which vest on the earlier of (i) June 17, 2027 or (ii) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":118650,"source":{"system":"sec-edgar","filing":"0001193125-26-274132","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1653087/000119312526274132/ownership.xml","form_type":"4"}},{"id":750901,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":37117,"kind":"person","name":"GAROFALO ELIZABETH A.","position":1,"cik":"0001826361","reported_name":"GAROFALO ELIZABETH A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2026-06-04T01:04:14.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":1593,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each RSU represents a contingent right to receive one Common Share vesting 100% on the earlier of (i) June 1, 2027 or (ii) the day before the date of the issuer's 2027 annual meeting of shareholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each RSU represents a contingent right to receive one Common Share vesting 100% on the earlier of (i) June 1, 2027 or (ii) the day before the date of the issuer's 2027 annual meeting of shareholders."}],"balance_after":1593,"derivative":{"exercise_price":0,"underlying":"Common Shares","underlying_shares":1593},"source":{"system":"sec-edgar","filing":"0001193125-26-256122","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1582313/000119312526256122/ownership.xml","form_type":"4"}},{"id":750900,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":37117,"kind":"person","name":"GAROFALO ELIZABETH A.","position":1,"cik":"0001826361","reported_name":"GAROFALO ELIZABETH A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2026-06-04T01:04:14.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":10507,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Vesting 100% on the earlier of (i) June 1, 2027 or (ii) the day before the date of the issuer's 2027 annual meeting of shareholders."}],"balance_after":10507,"derivative":{"exercise_price":53.46,"expiration_date":"2036-06-02","underlying":"Common Shares","underlying_shares":10507},"source":{"system":"sec-edgar","filing":"0001193125-26-256122","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1582313/000119312526256122/ownership.xml","form_type":"4"}},{"id":750899,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":37117,"kind":"person","name":"GAROFALO ELIZABETH A.","position":1,"cik":"0001826361","reported_name":"GAROFALO ELIZABETH A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2026-06-04T01:04:14.000Z","date":"2026-06-01","kind":"exercise","planned":false,"acquired":false,"shares":2645,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents Common Shares earned and vested under a restricted share unit (\"RSU\") award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents Common Shares earned and vested under a restricted share unit (\"RSU\") award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents Common Shares earned and vested under a restricted share unit (\"RSU\") award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders."}],"balance_after":0,"derivative":{"underlying":"Common Shares","underlying_shares":2645},"source":{"system":"sec-edgar","filing":"0001193125-26-256122","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1582313/000119312526256122/ownership.xml","form_type":"4"}},{"id":750898,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":37117,"kind":"person","name":"GAROFALO ELIZABETH A.","position":1,"cik":"0001826361","reported_name":"GAROFALO ELIZABETH A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-06-04T01:04:14.000Z","date":"2026-06-01","kind":"exercise","planned":false,"acquired":true,"shares":2645,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Common Shares earned and vested under a restricted share unit (\"RSU\") award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents Common Shares earned and vested under a restricted share unit (\"RSU\") award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders."}],"balance_after":2645,"source":{"system":"sec-edgar","filing":"0001193125-26-256122","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1582313/000119312526256122/ownership.xml","form_type":"4"}},{"id":757692,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":37117,"kind":"person","name":"GAROFALO ELIZABETH A.","position":1,"cik":"0001826361","reported_name":"GAROFALO ELIZABETH A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-01T22:00:10.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":9311,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units will vest in full on the earlier of one year following the date of grant or the next annual meeting of stockholders. The reporting person has elected to defer receipt of the shares of common stock underlying the restricted stock units until the earliest of the following: (i) the fifth anniversary of the date of grant of such restricted stock unit award; (ii) the date that is 30 days following the date on which the director ceases to serve as a member of the board of directors of the Issuer or otherwise provide services to the Issuer; and (iii) a change in control of the Issuer as defined in the Issuer's 2024 Equity Incentive Plan, as amended."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units will vest in full on the earlier of one year following the date of grant or the next annual meeting of stockholders. The reporting person has elected to defer receipt of the shares of common stock underlying the restricted stock units until the earliest of the following: (i) the fifth anniversary of the date of grant of such restricted stock unit award; (ii) the date that is 30 days following the date on which the director ceases to serve as a member of the board of directors of the Issuer or otherwise provide services to the Issuer; and (iii) a change in control of the Issuer as defined in the Issuer's 2024 Equity Incentive Plan, as amended."}],"balance_after":9311,"derivative":{"underlying":"Common Stock","underlying_shares":9311},"source":{"system":"sec-edgar","filing":"0001826361-26-000002","document":"form4-06012026_060603.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000182636126000002/form4-06012026_060603.xml","form_type":"4"}},{"id":757691,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":37117,"kind":"person","name":"GAROFALO ELIZABETH A.","position":1,"cik":"0001826361","reported_name":"GAROFALO ELIZABETH A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Options (Right to Buy)","published_at":"2026-06-01T22:00:10.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":16004,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to each stock option will vest quarterly over one year following the date of grant, with the final tranche vesting on the earlier of one year following the date of grant or the next annual meeting of stockholders."}],"balance_after":16004,"derivative":{"exercise_price":21.66,"expiration_date":"2036-05-28","underlying":"Common Stock","underlying_shares":16004},"source":{"system":"sec-edgar","filing":"0001826361-26-000002","document":"form4-06012026_060603.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000182636126000002/form4-06012026_060603.xml","form_type":"4"}},{"id":757690,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":37117,"kind":"person","name":"GAROFALO ELIZABETH A.","position":1,"cik":"0001826361","reported_name":"GAROFALO ELIZABETH A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-01T22:00:10.000Z","date":"2026-05-29","kind":"exercise","planned":false,"acquired":false,"shares":8107,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vested in full on May 29, 2026, the date on which an annual meeting of stockholders was held."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vested in full on May 29, 2026, the date on which an annual meeting of stockholders was held."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":8107},"source":{"system":"sec-edgar","filing":"0001826361-26-000002","document":"form4-06012026_060603.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000182636126000002/form4-06012026_060603.xml","form_type":"4"}},{"id":757689,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":37117,"kind":"person","name":"GAROFALO ELIZABETH A.","position":1,"cik":"0001826361","reported_name":"GAROFALO ELIZABETH A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-01T22:00:10.000Z","date":"2026-05-29","kind":"exercise","planned":false,"acquired":true,"shares":8107,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."}],"balance_after":33489,"source":{"system":"sec-edgar","filing":"0001826361-26-000002","document":"form4-06012026_060603.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000182636126000002/form4-06012026_060603.xml","form_type":"4"}},{"id":1050442,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":37117,"kind":"person","name":"GAROFALO ELIZABETH A.","position":1,"cik":"0001826361","reported_name":"GAROFALO ELIZABETH A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-03T22:00:05.000Z","date":"2025-09-02","kind":"sale","planned":false,"acquired":false,"shares":1600,"price":25.9753,"value":41560.48,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.97 to $25.991, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":25382,"source":{"system":"sec-edgar","filing":"0001415889-25-023592","document":"form4-09032025_060901.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588925023592/form4-09032025_060901.xml","form_type":"4"}},{"id":1112848,"issuer":{"id":6051,"kind":"organization","name":"Alector, Inc.","symbol":"ALEC"},"owners":[{"id":37117,"kind":"person","name":"GAROFALO ELIZABETH A.","position":1,"cik":"0001826361","reported_name":"GAROFALO ELIZABETH A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-12T22:05:09.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":9450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option vest in 12 equal monthly installments beginning on July 11, 2025, provided that the shares subject to the option will vest in full on the earlier of the one-year anniversary of the date of grant or the date of the Issuer's next annual meeting of stockholders."}],"balance_after":9450,"derivative":{"exercise_price":1.63,"expiration_date":"2035-06-10","underlying":"Common Stock","underlying_shares":9450},"source":{"system":"sec-edgar","filing":"0000950170-25-085618","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1653087/000095017025085618/ownership.xml","form_type":"4"}},{"id":1112847,"issuer":{"id":6051,"kind":"organization","name":"Alector, Inc.","symbol":"ALEC"},"owners":[{"id":37117,"kind":"person","name":"GAROFALO ELIZABETH A.","position":1,"cik":"0001826361","reported_name":"GAROFALO ELIZABETH A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-12T22:05:09.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":28700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares are represented by restricted stock units, or RSUs, which vest on the earlier of (i) June 11, 2026 or (ii) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":89950,"source":{"system":"sec-edgar","filing":"0000950170-25-085618","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1653087/000095017025085618/ownership.xml","form_type":"4"}},{"id":1119182,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":37117,"kind":"person","name":"GAROFALO ELIZABETH A.","position":1,"cik":"0001826361","reported_name":"GAROFALO ELIZABETH A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2025-06-06T21:59:26.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":2645,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each restricted share unit represents a contingent right to receive one Common Share vesting 100% on the earlier of (i) June 4, 2026 or (ii) the day before the date of the issuer's 2026 annual meeting of shareholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted share unit represents a contingent right to receive one Common Share vesting 100% on the earlier of (i) June 4, 2026 or (ii) the day before the date of the issuer's 2026 annual meeting of shareholders."}],"balance_after":2645,"derivative":{"exercise_price":0,"underlying":"Common Shares","underlying_shares":2645},"source":{"system":"sec-edgar","filing":"0000950170-25-083323","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1582313/000095017025083323/ownership.xml","form_type":"4"}},{"id":1119181,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":37117,"kind":"person","name":"GAROFALO ELIZABETH A.","position":1,"cik":"0001826361","reported_name":"GAROFALO ELIZABETH A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2025-06-06T21:59:26.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":17012,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vesting 100% on the earlier of (i) June 4, 2026 or (ii) the day before the date of the issuer's 2026 annual meeting of shareholders."}],"balance_after":17012,"derivative":{"exercise_price":30.73,"expiration_date":"2035-06-04","underlying":"Common Shares","underlying_shares":17012},"source":{"system":"sec-edgar","filing":"0000950170-25-083323","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1582313/000095017025083323/ownership.xml","form_type":"4"}},{"id":1128196,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":37117,"kind":"person","name":"GAROFALO ELIZABETH A.","position":1,"cik":"0001826361","reported_name":"GAROFALO ELIZABETH A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-06-02T22:05:08.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":8107,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units will vest in full on the earlier of one year following the date of grant or the next annual meeting of stockholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units will vest in full on the earlier of one year following the date of grant or the next annual meeting of stockholders."}],"balance_after":8107,"derivative":{"underlying":"Common Stock","underlying_shares":8107},"source":{"system":"sec-edgar","filing":"0001415889-25-015272","document":"form4-06022025_060605.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588925015272/form4-06022025_060605.xml","form_type":"4"}},{"id":1128195,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":37117,"kind":"person","name":"GAROFALO ELIZABETH A.","position":1,"cik":"0001826361","reported_name":"GAROFALO ELIZABETH A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Options (Right to Buy)","published_at":"2025-06-02T22:05:08.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":13793,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to each stock option will vest quarterly over one year following the date of grant, with the final tranche vesting on the earlier of one year following the date of grant or the next annual meeting of stockholders."}],"balance_after":13793,"derivative":{"exercise_price":22.29,"expiration_date":"2035-05-28","underlying":"Common Stock","underlying_shares":13793},"source":{"system":"sec-edgar","filing":"0001415889-25-015272","document":"form4-06022025_060605.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588925015272/form4-06022025_060605.xml","form_type":"4"}},{"id":1128194,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":37117,"kind":"person","name":"GAROFALO ELIZABETH A.","position":1,"cik":"0001826361","reported_name":"GAROFALO ELIZABETH A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-06-02T22:05:08.000Z","date":"2025-05-29","kind":"exercise","planned":false,"acquired":false,"shares":9387,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vested in full on May 29, 2025, the date on which an annual meeting of stockholders was held."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vested in full on May 29, 2025, the date on which an annual meeting of stockholders was held."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":9387},"source":{"system":"sec-edgar","filing":"0001415889-25-015272","document":"form4-06022025_060605.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588925015272/form4-06022025_060605.xml","form_type":"4"}},{"id":1128193,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":37117,"kind":"person","name":"GAROFALO ELIZABETH A.","position":1,"cik":"0001826361","reported_name":"GAROFALO ELIZABETH A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-02T22:05:08.000Z","date":"2025-05-29","kind":"exercise","planned":false,"acquired":true,"shares":9387,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."}],"balance_after":26982,"source":{"system":"sec-edgar","filing":"0001415889-25-015272","document":"form4-06022025_060605.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588925015272/form4-06022025_060605.xml","form_type":"4"}},{"id":1220349,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":37117,"kind":"person","name":"GAROFALO ELIZABETH A.","position":1,"cik":"0001826361","reported_name":"GAROFALO ELIZABETH A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-06T23:30:15.000Z","date":"2025-03-05","kind":"sale","planned":false,"acquired":false,"shares":4919,"price":18.23,"value":89673.37,"ownership":{"direct":true},"balance_after":17595,"source":{"system":"sec-edgar","filing":"0001415889-25-007299","document":"form4-03062025_060312.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588925007299/form4-03062025_060312.xml","form_type":"4"}},{"id":1481665,"issuer":{"id":6051,"kind":"organization","name":"Alector, Inc.","symbol":"ALEC"},"owners":[{"id":37117,"kind":"person","name":"GAROFALO ELIZABETH A.","position":1,"cik":"0001826361","reported_name":"GAROFALO ELIZABETH A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-12T20:46:08.000Z","date":"2024-06-12","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares are represented by restricted stock units, or RSUs, which vest on the earlier of (i) June 12, 2025 or (ii) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":61250,"source":{"system":"sec-edgar","filing":"0000950170-24-072516","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1653087/000095017024072516/ownership.xml","form_type":"4"}},{"id":1489461,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":37117,"kind":"person","name":"GAROFALO ELIZABETH A.","position":1,"cik":"0001826361","reported_name":"GAROFALO ELIZABETH A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-05T21:42:24.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":15542,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vesting 100% on the earlier of (i) June 4, 2025 or (ii) the day before the date of the issuer's 2025 annual meeting of shareholders."}],"balance_after":15542,"derivative":{"exercise_price":38.16,"expiration_date":"2034-06-04","underlying":"Common Shares","underlying_shares":15542},"source":{"system":"sec-edgar","filing":"0000950170-24-069465","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1582313/000095017024069465/ownership.xml","form_type":"4"}},{"id":1497028,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":37117,"kind":"person","name":"GAROFALO ELIZABETH A.","position":1,"cik":"0001826361","reported_name":"GAROFALO ELIZABETH A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-05-31T22:00:18.000Z","date":"2024-05-29","kind":"grant","planned":false,"acquired":true,"shares":9387,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units will vest in full on the earlier of one year following the date of grant or the next annual meeting of stockholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units will vest in full on the earlier of one year following the date of grant or the next annual meeting of stockholders."}],"balance_after":9387,"derivative":{"underlying":"Common Stock","underlying_shares":9387},"source":{"system":"sec-edgar","filing":"0001415889-24-015088","document":"form4-05312024_060514.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924015088/form4-05312024_060514.xml","form_type":"4"}},{"id":1497027,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":37117,"kind":"person","name":"GAROFALO ELIZABETH A.","position":1,"cik":"0001826361","reported_name":"GAROFALO ELIZABETH A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Options (Right to Buy)","published_at":"2024-05-31T22:00:18.000Z","date":"2024-05-29","kind":"grant","planned":false,"acquired":true,"shares":15959,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to each stock option will vest quarterly over one year following the date of grant, with the final tranche vesting on the earlier of one year following the date of grant or the next annual meeting of stockholders."}],"balance_after":15959,"derivative":{"exercise_price":14.62,"expiration_date":"2034-05-28","underlying":"Common Stock","underlying_shares":15959},"source":{"system":"sec-edgar","filing":"0001415889-24-015088","document":"form4-05312024_060514.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924015088/form4-05312024_060514.xml","form_type":"4"}},{"id":1497026,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":37117,"kind":"person","name":"GAROFALO ELIZABETH A.","position":1,"cik":"0001826361","reported_name":"GAROFALO ELIZABETH A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-05-31T22:00:18.000Z","date":"2024-05-29","kind":"exercise","planned":false,"acquired":false,"shares":6652,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vested in full on May 29, 2024, the date on which an annual meeting of stockholders was held."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vested in full on May 29, 2024, the date on which an annual meeting of stockholders was held."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":6652},"source":{"system":"sec-edgar","filing":"0001415889-24-015088","document":"form4-05312024_060514.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924015088/form4-05312024_060514.xml","form_type":"4"}},{"id":1497025,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":37117,"kind":"person","name":"GAROFALO ELIZABETH A.","position":1,"cik":"0001826361","reported_name":"GAROFALO ELIZABETH A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-31T22:00:18.000Z","date":"2024-05-29","kind":"exercise","planned":false,"acquired":true,"shares":6652,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."}],"balance_after":22514,"source":{"system":"sec-edgar","filing":"0001415889-24-015088","document":"form4-05312024_060514.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924015088/form4-05312024_060514.xml","form_type":"4"}},{"id":1583582,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":37117,"kind":"person","name":"GAROFALO ELIZABETH A.","position":1,"cik":"0001826361","reported_name":"GAROFALO ELIZABETH A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-12T00:09:29.000Z","date":"2024-03-08","kind":"exercise","planned":false,"acquired":false,"shares":3500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-third of the total shares subject to the Option vested on the one year anniversary of the grant date, one-third of the total shares subject to the Option vested on the two year anniversary of the grant date, and one-third of the total shares subject to the Option shall vest on the three year anniversary of the grant date."}],"balance_after":16500,"derivative":{"exercise_price":18.56,"expiration_date":"2031-06-02","underlying":"Common Shares","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000950170-24-029542","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1582313/000095017024029542/ownership.xml","form_type":"4"}},{"id":1583581,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":37117,"kind":"person","name":"GAROFALO ELIZABETH A.","position":1,"cik":"0001826361","reported_name":"GAROFALO ELIZABETH A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2024-03-12T00:09:29.000Z","date":"2024-03-08","kind":"sale","planned":false,"acquired":false,"shares":2092,"price":45.69,"value":95583.48,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-24-029542","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1582313/000095017024029542/ownership.xml","form_type":"4"}},{"id":1583580,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":37117,"kind":"person","name":"GAROFALO ELIZABETH A.","position":1,"cik":"0001826361","reported_name":"GAROFALO ELIZABETH A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2024-03-12T00:09:29.000Z","date":"2024-03-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":1408,"price":46.16,"value":64993.28,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the closing price of the Company's common shares on March 7, 2024 for purposes of net settlement calculations."}],"balance_after":2092,"source":{"system":"sec-edgar","filing":"0000950170-24-029542","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1582313/000095017024029542/ownership.xml","form_type":"4"}},{"id":1583579,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":37117,"kind":"person","name":"GAROFALO ELIZABETH A.","position":1,"cik":"0001826361","reported_name":"GAROFALO ELIZABETH A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2024-03-12T00:09:29.000Z","date":"2024-03-08","kind":"exercise","planned":false,"acquired":true,"shares":3500,"price":18.56,"value":64960.0,"ownership":{"direct":true},"balance_after":3500,"source":{"system":"sec-edgar","filing":"0000950170-24-029542","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1582313/000095017024029542/ownership.xml","form_type":"4"}},{"id":1719745,"issuer":{"id":6051,"kind":"organization","name":"Alector, Inc.","symbol":"ALEC"},"owners":[{"id":37117,"kind":"person","name":"GAROFALO ELIZABETH A.","position":1,"cik":"0001826361","reported_name":"GAROFALO ELIZABETH A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-06T23:30:12.000Z","date":"2023-12-05","kind":"gift","planned":false,"acquired":false,"shares":9459,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":26250,"source":{"system":"sec-edgar","filing":"0000950170-23-068620","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1653087/000095017023068620/ownership.xml","form_type":"4"}},{"id":1728908,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":37117,"kind":"person","name":"GAROFALO ELIZABETH A.","position":1,"cik":"0001826361","reported_name":"GAROFALO ELIZABETH A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-11-28T22:32:04.000Z","date":"2023-11-24","kind":"gift","planned":false,"acquired":false,"shares":2918,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects the gift of common stock to a charitable donor advised fund."}],"balance_after":15862,"source":{"system":"sec-edgar","filing":"0001209191-23-056827","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123056827/doc4.xml","form_type":"4"}},{"id":1853780,"issuer":{"id":6051,"kind":"organization","name":"Alector, Inc.","symbol":"ALEC"},"owners":[{"id":37117,"kind":"person","name":"GAROFALO ELIZABETH A.","position":1,"cik":"0001826361","reported_name":"GAROFALO ELIZABETH A.","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2023-06-15T20:01:11.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":12360,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option vest in 12 equal monthly installments beginning on July 14, 2023, provided that the shares subject to the option will vest in full on the earlier of the one-year anniversary of the date of grant or the date of the Issuer's next annual meeting of stockholders."}],"balance_after":12360,"derivative":{"exercise_price":7.71,"expiration_date":"2033-06-14","underlying":"Common Stock","underlying_shares":12360},"source":{"system":"sec-edgar","filing":"0000950170-23-028267","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1653087/000095017023028267/ownership.xml","form_type":"4"}},{"id":1853779,"issuer":{"id":6051,"kind":"organization","name":"Alector, Inc.","symbol":"ALEC"},"owners":[{"id":37117,"kind":"person","name":"GAROFALO ELIZABETH A.","position":1,"cik":"0001826361","reported_name":"GAROFALO ELIZABETH A.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-06-15T20:01:11.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":26250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares are represented by restricted stock units, or RSUs, which vest on the earlier of (i) June 14, 2024 or (ii) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":35709,"source":{"system":"sec-edgar","filing":"0000950170-23-028267","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1653087/000095017023028267/ownership.xml","form_type":"4"}},{"id":1867881,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":37117,"kind":"person","name":"GAROFALO ELIZABETH A.","position":1,"cik":"0001826361","reported_name":"GAROFALO ELIZABETH A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-06-06T01:34:45.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":6652,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Acadia common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units shall vest in full upon the earlier of one year following the date of grant or the next annual meeting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units shall vest in full upon the earlier of one year following the date of grant or the next annual meeting date."}],"balance_after":6652,"derivative":{"underlying":"Common Stock","underlying_shares":6652},"source":{"system":"sec-edgar","filing":"0001209191-23-034694","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123034694/doc4.xml","form_type":"4"}},{"id":1867880,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":37117,"kind":"person","name":"GAROFALO ELIZABETH A.","position":1,"cik":"0001826361","reported_name":"GAROFALO ELIZABETH A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Options (Right to Buy)","published_at":"2023-06-06T01:34:45.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":11045,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option shall vest quarterly over one year following the date of grant, with the final tranche vesting upon the earlier of one year following the date of grant or the next annual meeting date."}],"balance_after":11045,"derivative":{"exercise_price":23.9,"expiration_date":"2033-05-31","underlying":"Common Stock","underlying_shares":11045},"source":{"system":"sec-edgar","filing":"0001209191-23-034694","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123034694/doc4.xml","form_type":"4"}},{"id":1867879,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":37117,"kind":"person","name":"GAROFALO ELIZABETH A.","position":1,"cik":"0001826361","reported_name":"GAROFALO ELIZABETH A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-06-06T01:34:45.000Z","date":"2023-06-01","kind":"exercise","planned":false,"acquired":false,"shares":8552,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Acadia common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units shall vest in full upon the earlier of one year following the date of grant or the next annual meeting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units shall vest in full upon the earlier of one year following the date of grant or the next annual meeting date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":8552},"source":{"system":"sec-edgar","filing":"0001209191-23-034694","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123034694/doc4.xml","form_type":"4"}},{"id":1867878,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":37117,"kind":"person","name":"GAROFALO ELIZABETH A.","position":1,"cik":"0001826361","reported_name":"GAROFALO ELIZABETH A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-06-06T01:34:45.000Z","date":"2022-09-29","kind":"exercise","planned":false,"acquired":false,"shares":1919,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Acadia common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units shall vest in two equal annual installments commencing on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units shall vest in two equal annual installments commencing on the first anniversary of the grant date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1919},"source":{"system":"sec-edgar","filing":"0001209191-23-034694","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123034694/doc4.xml","form_type":"4"}},{"id":1867877,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":37117,"kind":"person","name":"GAROFALO ELIZABETH A.","position":1,"cik":"0001826361","reported_name":"GAROFALO ELIZABETH A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-06-06T01:34:45.000Z","date":"2022-06-07","kind":"exercise","planned":false,"acquired":false,"shares":6391,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Acadia common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units shall vest in full upon the earlier of one year following the date of grant or the next annual meeting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units shall vest in full upon the earlier of one year following the date of grant or the next annual meeting date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":6391},"source":{"system":"sec-edgar","filing":"0001209191-23-034694","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123034694/doc4.xml","form_type":"4"}},{"id":1867876,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":37117,"kind":"person","name":"GAROFALO ELIZABETH A.","position":1,"cik":"0001826361","reported_name":"GAROFALO ELIZABETH A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-06T01:34:45.000Z","date":"2023-06-01","kind":"exercise","planned":false,"acquired":true,"shares":8552,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Acadia common stock."}],"balance_after":18780,"source":{"system":"sec-edgar","filing":"0001209191-23-034694","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123034694/doc4.xml","form_type":"4"}},{"id":1867875,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":37117,"kind":"person","name":"GAROFALO ELIZABETH A.","position":1,"cik":"0001826361","reported_name":"GAROFALO ELIZABETH A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-06T01:34:45.000Z","date":"2022-09-29","kind":"exercise","planned":false,"acquired":true,"shares":1919,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Acadia common stock."}],"balance_after":10228,"source":{"system":"sec-edgar","filing":"0001209191-23-034694","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123034694/doc4.xml","form_type":"4"}},{"id":1867874,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":37117,"kind":"person","name":"GAROFALO ELIZABETH A.","position":1,"cik":"0001826361","reported_name":"GAROFALO ELIZABETH A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-06T01:34:45.000Z","date":"2022-06-07","kind":"exercise","planned":false,"acquired":true,"shares":6391,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Acadia common stock."}],"balance_after":8309,"source":{"system":"sec-edgar","filing":"0001209191-23-034694","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123034694/doc4.xml","form_type":"4"}},{"id":1869100,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":37117,"kind":"person","name":"GAROFALO ELIZABETH A.","position":1,"cik":"0001826361","reported_name":"GAROFALO ELIZABETH A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-02T21:22:26.000Z","date":"2023-06-02","kind":"grant","planned":false,"acquired":true,"shares":18475,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vesting 100% on the earlier of (i) June 1, 2024 or (ii) the day immediately preceding the day of the following year's annual meeting."}],"balance_after":18475,"derivative":{"exercise_price":38.96,"expiration_date":"2033-06-01","underlying":"Common Shares","underlying_shares":18475},"source":{"system":"sec-edgar","filing":"0000950170-23-026171","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1582313/000095017023026171/ownership.xml","form_type":"4"}},{"id":2219187,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":37117,"kind":"person","name":"GAROFALO ELIZABETH A.","position":1,"cik":"0001826361","reported_name":"GAROFALO ELIZABETH A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-29T21:31:02.000Z","date":"2022-06-28","kind":"grant","acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the common shares subject to the option will vest on the earlier of (i) the first anniversary of grant date and (ii) the day immediately preceding the day of the Issuer's next annual general meeting of shareholders."}],"balance_after":18000,"derivative":{"exercise_price":30.11,"expiration_date":"2032-06-27","underlying":"Common Shares","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001209191-22-039829","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1582313/000120919122039829/doc4.xml","form_type":"4"}},{"id":2224871,"issuer":{"id":6051,"kind":"organization","name":"Alector, Inc.","symbol":"ALEC"},"owners":[{"id":37117,"kind":"person","name":"GAROFALO ELIZABETH A.","position":1,"cik":"0001826361","reported_name":"GAROFALO ELIZABETH A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-21T23:18:18.000Z","date":"2022-06-16","kind":"grant","acquired":true,"shares":18918,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option vest in 12 equal monthly installments beginning on July 16, 2022, or if earlier, the date of the Issuer's next annual meeting of stockholders."}],"balance_after":18918,"derivative":{"exercise_price":8.07,"expiration_date":"2032-06-16","underlying":"Common Stock","underlying_shares":18918},"source":{"system":"sec-edgar","filing":"0001209191-22-038536","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1653087/000120919122038536/doc4.xml","form_type":"4"}},{"id":2224870,"issuer":{"id":6051,"kind":"organization","name":"Alector, Inc.","symbol":"ALEC"},"owners":[{"id":37117,"kind":"person","name":"GAROFALO ELIZABETH A.","position":1,"cik":"0001826361","reported_name":"GAROFALO ELIZABETH A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-21T23:18:18.000Z","date":"2022-06-16","kind":"grant","acquired":true,"shares":9459,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares are represented by restricted stock units, or RSUs, which vest on the earlier of (i) June 16, 2023 or (ii) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":9459,"source":{"system":"sec-edgar","filing":"0001209191-22-038536","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1653087/000120919122038536/doc4.xml","form_type":"4"}},{"id":2231049,"issuer":{"id":8068,"kind":"organization","name":"EXICURE, INC."},"owners":[{"id":37117,"kind":"person","name":"GAROFALO ELIZABETH A.","position":1,"cik":"0001826361","reported_name":"GAROFALO ELIZABETH A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-06-15T20:21:03.000Z","date":"2022-06-13","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest as to 1/12th of the underlying shares monthly from the vesting commencement date of June 13, 2022, provided the Reporting Person remains in continuous service on each vesting date."}],"balance_after":50000,"derivative":{"exercise_price":0.126,"expiration_date":"2032-06-12","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-22-036947","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1698530/000120919122036947/doc4.xml","form_type":"4"}},{"id":2238140,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":37117,"kind":"person","name":"GAROFALO ELIZABETH A.","position":1,"cik":"0001826361","reported_name":"GAROFALO ELIZABETH A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-06-10T00:34:01.000Z","date":"2022-06-07","kind":"grant","acquired":true,"shares":8552,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Acadia common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units shall vest in full upon the earlier of one year following the date of grant or the next annual meeting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units shall vest in full upon the earlier of one year following the date of grant or the next annual meeting date."}],"balance_after":8552,"derivative":{"underlying":"Common Stock","underlying_shares":8552},"source":{"system":"sec-edgar","filing":"0001209191-22-035670","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919122035670/doc4.xml","form_type":"4"}},{"id":2238139,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":37117,"kind":"person","name":"GAROFALO ELIZABETH A.","position":1,"cik":"0001826361","reported_name":"GAROFALO ELIZABETH A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Options (Right to Buy)","published_at":"2022-06-10T00:34:01.000Z","date":"2022-06-07","kind":"grant","acquired":true,"shares":14368,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest quarterly over one year following the date of grant, with the final tranche vesting upon the earlier of one year following the date of grant or the next annual meeting date."}],"balance_after":14368,"derivative":{"exercise_price":18.27,"expiration_date":"2032-06-06","underlying":"Common Stock","underlying_shares":14368},"source":{"system":"sec-edgar","filing":"0001209191-22-035670","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919122035670/doc4.xml","form_type":"4"}},{"id":2554888,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":37117,"kind":"person","name":"GAROFALO ELIZABETH A.","position":1,"cik":"0001826361","reported_name":"GAROFALO ELIZABETH A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-10-01T21:33:29.000Z","date":"2021-09-29","kind":"exercise","acquired":true,"shares":1918,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units shall vest in two equal annual installments commencing September 29, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units shall vest in two equal annual installments commencing September 29, 2021."}],"balance_after":1919,"derivative":{"underlying":"Common Stock","underlying_shares":1918},"source":{"system":"sec-edgar","filing":"0001209191-21-058556","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919121058556/doc4.xml","form_type":"4"}},{"id":2554887,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":37117,"kind":"person","name":"GAROFALO ELIZABETH A.","position":1,"cik":"0001826361","reported_name":"GAROFALO ELIZABETH A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-01T21:33:29.000Z","date":"2021-09-29","kind":"exercise","acquired":true,"shares":1918,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock."}],"balance_after":1918,"source":{"system":"sec-edgar","filing":"0001209191-21-058556","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919121058556/doc4.xml","form_type":"4"}},{"id":2558543,"issuer":{"id":6051,"kind":"organization","name":"Alector, Inc.","symbol":"ALEC"},"owners":[{"id":37117,"kind":"person","name":"GAROFALO ELIZABETH A.","position":1,"cik":"0001826361","reported_name":"GAROFALO ELIZABETH A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-09-28T00:00:48.000Z","date":"2021-09-23","kind":"grant","acquired":true,"shares":33235,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth of the shares subject to the option vest on September 23, 2022 and 1/48th of the shares vest monthly thereafter."}],"balance_after":33235,"derivative":{"exercise_price":24.26,"expiration_date":"2031-09-23","underlying":"Common Stock","underlying_shares":33235},"source":{"system":"sec-edgar","filing":"0001209191-21-057851","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1653087/000120919121057851/doc4.xml","form_type":"4"}},{"id":2656310,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":37117,"kind":"person","name":"GAROFALO ELIZABETH A.","position":1,"cik":"0001826361","reported_name":"GAROFALO ELIZABETH A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-06-24T20:41:06.000Z","date":"2021-06-22","kind":"grant","acquired":true,"shares":6391,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units shall vest in full upon the earlier of one year following the date of grant or the next annual meeting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units shall vest in full upon the earlier of one year following the date of grant or the next annual meeting date."}],"balance_after":6391,"derivative":{"underlying":"Common Stock","underlying_shares":6391},"source":{"system":"sec-edgar","filing":"0001209191-21-043039","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919121043039/doc4.xml","form_type":"4"}},{"id":2656309,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":37117,"kind":"person","name":"GAROFALO ELIZABETH A.","position":1,"cik":"0001826361","reported_name":"GAROFALO ELIZABETH A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Options (Right to Buy)","published_at":"2021-06-24T20:41:06.000Z","date":"2021-06-22","kind":"grant","acquired":true,"shares":11637,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest quarterly over one year following the date of grant, with the final tranche vesting upon the earlier of one year following the date of grant or the next annual meeting date."}],"balance_after":11637,"derivative":{"exercise_price":24.88,"expiration_date":"2031-06-21","underlying":"Common Stock","underlying_shares":11637},"source":{"system":"sec-edgar","filing":"0001209191-21-043039","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919121043039/doc4.xml","form_type":"4"}},{"id":2680384,"issuer":{"id":8068,"kind":"organization","name":"EXICURE, INC."},"owners":[{"id":37117,"kind":"person","name":"GAROFALO ELIZABETH A.","position":1,"cik":"0001826361","reported_name":"GAROFALO ELIZABETH A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-04T21:14:34.000Z","date":"2021-06-02","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest as to 1/12 of the underlying shares monthly from the vesting commencement date of June 2, 2021, provided the Reporting Person remains in continuous service on each vesting date."}],"balance_after":50000,"derivative":{"exercise_price":1.71,"expiration_date":"2031-06-01","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-21-038319","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1698530/000120919121038319/doc4.xml","form_type":"4"}},{"id":2682350,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":37117,"kind":"person","name":"GAROFALO ELIZABETH A.","position":1,"cik":"0001826361","reported_name":"GAROFALO ELIZABETH A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-04T01:00:30.000Z","date":"2021-06-03","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the total shares subject to the Option shall vest on the one year anniversary of the grant date, one-third of the total shares subject to the Option shall vest on the two year anniversary of the grant\ndate, one-third of the total shares subject to the Option shall vest on the three year anniversary of the grant date."}],"balance_after":20000,"derivative":{"exercise_price":18.56,"expiration_date":"2031-06-02","underlying":"Common Shares","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-21-038055","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1582313/000120919121038055/doc4.xml","form_type":"4"}},{"id":2802477,"issuer":{"id":8068,"kind":"organization","name":"EXICURE, INC."},"owners":[{"id":37117,"kind":"person","name":"GAROFALO ELIZABETH A.","position":1,"cik":"0001826361","reported_name":"GAROFALO ELIZABETH A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-03-08T23:57:21.000Z","date":"2021-03-05","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in 36 substantially equal monthly installments from the vesting commencement date of March 5, 2021, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":100000,"derivative":{"exercise_price":2.06,"expiration_date":"2031-03-04","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-21-018736","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1698530/000120919121018736/doc4.xml","form_type":"4"}},{"id":3018859,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":37117,"kind":"person","name":"GAROFALO ELIZABETH A.","position":1,"cik":"0001826361","reported_name":"GAROFALO ELIZABETH A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-10-01T21:04:17.000Z","date":"2020-09-29","kind":"grant","acquired":true,"shares":3837,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units shall vest in two equal annual installments commencing on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units shall vest in two equal annual installments commencing on the first anniversary of the grant date."}],"balance_after":3837,"derivative":{"underlying":"Common Stock","underlying_shares":3837},"source":{"system":"sec-edgar","filing":"0001209191-20-052665","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919120052665/doc4.xml","form_type":"4"}},{"id":3018858,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":37117,"kind":"person","name":"GAROFALO ELIZABETH A.","position":1,"cik":"0001826361","reported_name":"GAROFALO ELIZABETH A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-01T21:04:17.000Z","date":"2020-09-29","kind":"grant","acquired":true,"shares":6865,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the stock option shall vest in two equal annual installments commencing on the first anniversary of the grant date."}],"balance_after":6865,"derivative":{"exercise_price":40.41,"expiration_date":"2030-09-28","underlying":"Common Stock","underlying_shares":6865},"source":{"system":"sec-edgar","filing":"0001209191-20-052665","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919120052665/doc4.xml","form_type":"4"}}]}